Publications by authors named "Oliver Peyrony"

Background: We described the real-life epidemiology and causes of infections on the different therapy phases in patients undergoing chimeric antigen receptor (CAR) T-cells directed towards CD19+ or BCMA+ cells.

Methods: All consecutive patients receiving CAR T-cell therapy at our institution were prospectively followed-up. We performed various comparative analyses of all patients and subgroups with and without infections.

View Article and Find Full Text PDF
Article Synopsis
  • Pseudomonas aeruginosa bloodstream infections (BSI) in febrile neutropenic patients show a growing challenge due to increasing antibiotic resistance, complicating effective treatment based on international guidelines.
  • A study involving 280 BSI cases revealed that 36% of isolated P. aeruginosa strains were resistant to recommended β-lactam antibiotics, with 21.1% classified as multidrug-resistant (MDR) and 11.4% as extensively drug-resistant (XDR).
  • Inappropriate empirical antibiotic treatment (IEAT) was administered to 16.8% of patients, contributing to a 30-day mortality rate of 27.1%, highlighting an urgent need for new treatment strategies.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined the epidemiology of invasive fungal infections (IFIs) in hospitalized patients over a four-year period, finding a total of 367 diagnosed cases.
  • Key risk factors included corticosteroid use (41.4%) and prior viral infection (31.3%), with the most common infections being candidemia (42.2%) and invasive aspergillosis (26.7%).
  • The overall mortality rate at 12 weeks post-diagnosis was 32.2%, highlighting the need for improved awareness and aggressive treatment methods among healthcare providers, especially given the increasing occurrences of resistant fungal strains.
View Article and Find Full Text PDF